PET examinations
Our laboratory is a unique place where we have located two hybrid PET/MR and PET/CT scanners. Both allow us to perform fully diagnostic MR and CT examinations. Therefore, we have the ability to offer patients full diagnostics in one place, and for scientists to carry out comparative studies. We also invite you to see the range of radiopharmaceuticals used in our laboratory.
PET/MR vs. PET/CT
These two techniques have many things in common and a number of differences at the same time. On our website, we provide you information that will help you choose the method optimally for the patient’s needs. A comparison of these techniques was conducted by a center in Germany, more information in this article or at http://jnm.snmjour1nals.org/content/61/8/1131.
List of the most important publications
We present you a list of publications on the technique of positron emission tomography with magnetic resonance (PET/MR) and computed tomography (PET/CT).
PET/MR publications
Simultaneous PET/MR diagnostic examinations are a very innovative and recently used method. Therefore, most scientific reports are available only in English. Below is a list of the most important publications on PET/MR diagnostic examinations.
1. Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies
Ashkan Heshmatzadeh Behzadi MD, Syed Imran Raza MBBS, John A. Carrino MD, MPH, Christos Kosmas MD, Ali Gholamrezanezhad MD, Kyle Basques MD, George R. Matcuk Jr MD, Jay Patel MD, Hossein Jadvar MD, PhD, MPH, MBA
PET Clin. 2018 Oct;13(4):623-634. doi: 10.1016/j.cpet.2018.05.012. Epub 2018 Aug 17
2. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Diomidis BotsikasIlias, Bagetakos Marlise Picarra, Ana Carolina Da Cunha, Afonso Barisits, Sana Boudabbous, Xavier Montet, Giang Thanh, LamIsmini Mainta, Anastasia Kalovidouri, Minerva Becker
Eur Radiol. 2018 Sep 28. doi: 10.1007/s00330-018-5720-8. [Epub ahead of print]
3. Znaczenie pozytonowej tomografii emisyjnej (PET) w diagnostyce schorzeń onkologicznych
Leszek Królicki, Jolanta Kunikowska, Małgorzata Kobylecka, Joanna Mączewska, Katarzyna Fronczewska
Postępy Nauk Medycznych 2/2011, s. 104-108
4. Chapter Four – Hybrid PET/MRI Methodology
MarcoAiello, CarloCavaliere, RoccoMarchitelli, Antoniod’Albore, EnricoDe Vita, MarcoSalvatore
Int Rev Neurobiol. 2018;141:97-128. doi: 10.1016/bs.irn.2018.07.026. Epub 2018 Aug 24.
5. Hybrid imaging with PET/MRI: ready for clinical routine?
Jiri Ferda, Eur J Radiol. 2017 Sep;94:A1-A2. doi: 10.1016/j.ejrad.2017.05.004. Epub 2017 May 9.
6. A multi-parametric PET/MRI study of breast cancer: Evaluation of DCE-MRI pharmacokinetic models and correlation with diffusion and functional parameters
Marianna Inglese,, Carlo Cavaliere Serena Monti, Ernesto Forte, Mariarosaria Incoronato Emanuele Nicolai , Marco Salvatore, Marco Aiello
NMR Biomed. 2018 Oct 31:e4026. doi: 10.1002/nbm.4026. [Epub ahead of print]
7. PET/MR in Breast Cancer
ClaireTabouret-Viaud MD, Diomidis Botsikas MD, Bénédicte M.A. Delattre PhD, Ismini Mainta MD, Gaël Amzalag MD, Olivier Rager MD, Vincent Vinh-Hung MD, Raymond Miralbell MD, Osman Ratib MD, PhD
Semin Nucl Med. 2015 Jul;45(4):304-21. doi: 10.1053/j.semnuclmed.2015.03.003.
8. PET/MR Imaging of the Pancreas
NadineMallakMDaThomas A.HopeMDbAlexander R.GuimaraesMD, PhDa
Magn Reson Imaging Clin N Am. 2018 Aug;26(3):345-362. doi: 10.1016/j.mric.2018.03.003.
9. Competitive advantage of PET/MRI
Hossein Jadvar, MD, PhD, MPH, MBA and Patrick M. Colletti, MD
Eur J Radiol. 2014 Jan;83(1):84-94. doi: 10.1016/j.ejrad.2013.05.028. Epub 2013 Jun 18.
10. PET/MRI in children
Sergios Gatidisa, Benjamin Benderb, Matthias Reimoldc, Jürgen F. Schäfera
Eur J Radiol. 2017 Sep;94:A64-A70. doi: 10.1016/j.ejrad.2017.01.018. Epub 2017 Jan 21.
11. PET/MR imaging of pelvic malignancies
Axel Wetter (M.D.), Johannes Grueneisen (M.D.), Lale Umutlu (M.D.)
Eur J Radiol. 2017 Sep;94:A44-A51. doi: 10.1016/j.ejrad.2017.02.026. Epub 2017 Feb 20.
12. Clinical applications of PET/MRI: current status and future perspectives
Felix Nensa, Karsten Beiderwellen, Philipp Heusch, Axel Wetter
Diagn Interv Radiol 2014; 20:438–447
13. Potential Pediatric Applications of PET/MR
Sandra Purz*1, Osama Sabri*1, Adrian Viehweger2, Henryk Barthel1, Regine Kluge1, Ina Sorge2, and Franz Wolfgang Hirsch2
J Nucl Med. 2014 Jun 1;55(Supplement 2):32S-39S. Epub 2014 Apr 24.
PET/CT publications
1. Wartość kliniczna badania PET/CT w różnicowaniu guzów trzustki – analiza 52 przypadków
Zbigniew Kula, Bogdan Małkowski, Jarosław Szefer
Przegląd Gastroenterologiczny 2008; 3 (4): 185–191, data publikacji online: 2008/09/05
2. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study
ChristopherKlenkMDaRakheeGawandeMDaLebrizUsluMDaAmanKhuranaMDaDeqiangQiuPhDaAndrewQuonMDaJessicaDonigBAaJarrettRosenbergPhDaSandraLuna-FinemanMDbProfMichaelMoseleyPhDaDrHeike EDaldrup-LinkMDa
Lancet Oncol. 2014 Mar;15(3):275-85. doi: 10.1016/S1470-2045(14)70021-X. Epub 2014 Feb 19.
3. 18F-FDG-PET/CT in Potentially Advanced Renal Cell Carcinoma: A Role in Treatment Decisions and Prognosis Estimation
JIRI FERDA1EVA FERDOVA1, MILAN HORA2, ONDREJ HES3, JINDRICH FINEK4, ONDREJ TOPOLCAN5 and BORIS KREUZBERG1
Anticancer Res. 2013 Jun;33(6):2665-72.
4. PET/CT for the staging and follow-up of patients with malignancies
T.D.PoeppelaB.J.KrausebT.A.HeusnercC.BoyaA.BockischaG.Antochc
Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29.
5. The impact of PET/CT scanning on the size of target volumes, radiation exposure of organs at risk, TCP and NTCP, in the radiotherapy planning of non-small cell lung cancer
Radovan Vojtíšek, Jan Mužík, Pavel Šlampa, Marie Budíková, Jaroslav Hejsek, Petr Smolák, Jiří Ferda and Jindřich Fíneka
Rep Pract Oncol Radiother. 2013 Oct 17;19(3):182-90. doi: 10.1016/j.rpor.2013.09.006. eCollection 2014 May.
6. The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin
Cuneyt Tamam, Muge Tamam,1 and Mehmet Mulazimoglu
World J Nucl Med. 2016 May-Aug;15(2):124-9. doi: 10.4103/1450-1147.176885.
7. Prognostic significance of maximum standardized uptake value on 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas
Cüneyt Tamam, MD, Müge Tamam, MD
Eklem Hastalik Cerrahisi. 2018 Dec;29(3):184-8. doi: 10.5606/ehc.2018.60419.
